Literature DB >> 29083465

Management of Breast Cancer Therapy-Related Sexual Dysfunction.

Caitlin E Taylor, Jane Lowe Meisel.   

Abstract

Sexual dysfunction is a prevalent concern among breast cancer survivors, and is often multifactorial in nature. Causes can be both physiologic and psychological; chemotherapy, endocrine therapy, and disfigurement from breast cancer surgery can all play a role. Sexual dysfunction can have a profound impact on quality of life and relationships and can also impact adherence to endocrine therapy. However, it can be a difficult topic for both patients and providers to bring up, and as a result, it is often inadequately addressed. Here, we will review the mechanisms of sexual dysfunction that occurs after breast cancer, offer some practical guidance on how to discuss this effectively with patients, and review the data and our recommendations for optimizing management.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29083465

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  3 in total

Review 1.  Sexual Health in Menopause.

Authors:  Irene Scavello; Elisa Maseroli; Vincenza Di Stasi; Linda Vignozzi
Journal:  Medicina (Kaunas)       Date:  2019-09-02       Impact factor: 2.430

Review 2.  Sexual dysfunction as a challenge in treated breast cancer: in-depth analysis and risk assessment to improve individual outcomes.

Authors:  Abraham Hernández-Blanquisett; Valeria Quintero-Carreño; Angelina Álvarez-Londoño; María Cristina Martínez-Ávila; Raissa Diaz-Cáceres
Journal:  Front Oncol       Date:  2022-08-02       Impact factor: 5.738

Review 3.  Hyaluronic Acid: A Valid Therapeutic Option for Early Management of Genitourinary Syndrome of Menopause in Cancer Survivors?

Authors:  Rossella E Nappi; Silvia Martella; Francesca Albani; Chiara Cassani; Ellis Martini; Fabio Landoni
Journal:  Healthcare (Basel)       Date:  2022-08-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.